Funding gap for immunization across 94 low- and middle-income countries

被引:17
|
作者
Ozawa, Sachiko [1 ]
Grewal, Simrun [2 ]
Portnoy, Allison [3 ]
Sinha, Anushua [4 ,6 ]
Arilotta, Richard [4 ]
Stack, Meghan L.
Brenzel, Logan [5 ]
机构
[1] Univ North Carolina Chapel Hill, UNC Eshelman Sch Pharm, Div Practice Adv & Clin Educ, Chapel Hill, NC USA
[2] Univ Washington, Dept Pharm, Seattle, WA 98195 USA
[3] Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA USA
[4] Rutgers State Univ, New Jersey Med Sch, Dept Prevent Med & Community Hlth, Newark, NJ USA
[5] Bill & Melinda Gates Fdn, Washington, DC USA
[6] Merck & Co Inc, Ctr Outcomes & Real World Evidence, Rahway, NJ 07065 USA
基金
比尔及梅琳达.盖茨基金会;
关键词
Funding gap; Financing; Vaccine; Low- and middle-income country; Immunization; ROUTINE IMMUNIZATION; COSTS; VACCINES; IMPACT; PROGRAMS; STORAGE;
D O I
10.1016/j.vaccine.2016.09.036
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Novel vaccine development and production has given rise to a growing number of vaccines that can prevent disease and save lives. In order to realize these health benefits, it is essential to ensure adequate immunization financing to enable equitable access to vaccines for people in all communities. This analysis estimates the full immunization program costs, projected available financing, and resulting funding gap for 94 low- and middle-income countries over five years (2016-2020). Vaccine program financing by country governments, Gavi, and other development partners was forecasted for vaccine, supply chain, and service delivery, based on an analysis of comprehensive multi-year plans together with a series of scenario and sensitivity analyses. Findings indicate that delivery of full vaccination programs across 94 countries would result in a total funding gap of $7.6 billion (95% uncertainty range: $4.6-$11.8 billion) over 2016-2020, with the bulk (98%) of the resources required for routine immunization programs. More than half (65%) of the resources to meet this funding gap are required for service delivery at $5.0 billion ($2.7-$8.4 billion) with an additional $1.1 billion ($0.9-$2.7 billion) needed for vaccines and $1.5 billion ($1.1-$2.0 billion) for supply chain. When viewed as a percentage of total projected costs, the funding gap represents 66% of projected supply chain costs, 30% of service delivery costs, and 9% of vaccine costs. On average, this funding gap corresponds to 0.2% of general government expenditures and 23% of government health expenditures. These results suggest greater need for country and donor resource mobilization and funding allocation for immunizations. Both service delivery and supply chain are important areas for further resource mobilization. Further research on the impact of advances in service delivery technology and reductions in vaccine prices beyond this decade would be important for efficient investment decisions for immunization. (C) 2016 The Authors. Published by Elsevier Ltd.
引用
收藏
页码:6408 / 6416
页数:9
相关论文
共 50 条
  • [1] Financing And Funding Gap For 16 Vaccines Across 94 Low- And Middle-Income Countries, 2011-30
    Sriudomporn, Salin
    Sim, So Yoon
    Mak, Joshua
    Brenzel, Logan
    Patenaude, Bryan N.
    [J]. HEALTH AFFAIRS, 2023, 42 (01) : 94 - 104
  • [2] Costs of vaccine programs across 94 low- and middle-income countries
    Portnoy, Allison
    Ozawa, Sachiko
    Grewal, Simrun
    Norman, Bryan A.
    Rajgopal, Jayant
    Gorham, Katrin M.
    Haidari, Leila A.
    Brown, Shawn T.
    Lee, Bruce Y.
    [J]. VACCINE, 2015, 33 : A99 - A108
  • [3] Funding emergency medicine development in low- and middle-income countries
    Doney, MK
    Smith, J
    Kapur, GB
    [J]. EMERGENCY MEDICINE CLINICS OF NORTH AMERICA, 2005, 23 (01) : 45 - +
  • [4] Costs of Immunization Programs for 10 Vaccines in 94 Low- and Middle-Income Countries From 2011 to 2030
    Sim, So Yoon
    Watts, Elizabeth
    Constenla, Dagna
    Huang, Shuoning
    Brenzel, Logan
    Patenaude, Bryan N.
    [J]. VALUE IN HEALTH, 2021, 24 (01) : 70 - 77
  • [5] Cancer rehabilitation: closing the gap in low- and middle-income countries
    Anwar, Sumadi L.
    Adistyawan, Guritno
    Wulaningsih, Wahyu
    Erlangga, Zulrahman
    Gutenbrunner, Christoph
    Nugraha, Boya
    [J]. EUROPEAN JOURNAL OF PHYSICAL AND REHABILITATION MEDICINE, 2019, 55 (04) : 536 - 538
  • [6] The translational gap for gene therapies in low- and middle-income countries
    Doxzen, Kevin W.
    Adair, Jennifer E.
    Fonseca Bazzo, Yris Maria
    Bukini, Daima
    Cornetta, Kenneth
    Dalal, Varsha
    Guerino-Cunha, Renato Luiz
    Hongeng, Suradej
    Jotwani, Geeta
    Kityo-Mutuluuza, Cissy
    Lakshmanan, Krishnamurti
    Mahlangu, Johnny
    Makani, Julie
    Mathews, Vikram
    Ozelo, Margareth C.
    Rangarajan, Savita
    Scholefield, Janine
    Silva Junior, Joao Batista
    Mccune, Joseph M.
    [J]. SCIENCE TRANSLATIONAL MEDICINE, 2024, 16 (746)
  • [7] Funding sources for research: A research primer for low- and middle-income countries
    DeVos, Elizabeth
    Simon, Erin L.
    Aluisio, Adam
    [J]. AFRICAN JOURNAL OF EMERGENCY MEDICINE, 2020, 10 : S130 - S134
  • [8] Funding agencies in low- and middle-income countries: support for knowledge translation
    Cordero, Cynthia
    Delino, Rachel
    Jeyaseelan, L.
    Lansang, Mary Ann
    Lozano, Juan M.
    Kumar, Shuba
    Moreno, Socorro
    Pietersen, Merle
    Quirino, Jose
    Thamlikitkul, Visanu
    Welch, Vivian A.
    Tetroe, Jacqueline
    ter Kuile, Aleida
    Graham, Ian D.
    Grimshaw, Jeremy
    Neufeld, Vic
    Wells, George
    Tugwell, Peter
    [J]. BULLETIN OF THE WORLD HEALTH ORGANIZATION, 2008, 86 (07) : 524 - 534
  • [9] Science funding in low- and middle-income countries: the example of vaccine research
    Branston, R. H.
    Whitworth, J. A. G.
    [J]. MUCOSAL IMMUNOLOGY, 2009, 2 (04) : 280 - 283